Differential tissue and subcellular expression of ERM proteins in normal and malignant tissues: Cytoplasmic ezrin expression has prognostic significance for head and neck squamous cell carcinoma

Head and Neck

Volumn 28, Issue 11, 2006, Pages 1018-1027

  Madan, Rashna ^a   Brandwein Gensler, Margaret ^a   Schlecht, Nicolas F ^a   Elias, Kristin ^a   Gorbovitsky, Eleanor ^a   Belbin, Thomas J ^a   Mahmood, Radma ^a   Breining, Dwayne ^a   Qian, Hong ^a   Childs, Geoffrey ^a   Locker, Joseph ^a   Smith, Richard ^c   Haigentz Jr , Missak ^c   Gunn Moore, Frank ^b   Prystowsky, Michael B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Ezrin; Head and neck neoplasms; Immunohistochemistry; Moesin; Survival analysis

Indexed keywords

EZRIN; MOESIN; PROTEIN ERM; RADIXIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL MOTILITY; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PILOT STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYTOPLASM; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL MUCOSA; LARYNGEAL NEOPLASMS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PILOT PROJECTS; PROGNOSIS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33750375071     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20435     Document Type: Article

References (39)

1. Bretscher A. Regulation of cortical structure by the ezrin-radixin-moesin protein family. Curr Opin Cell Biol 1999;11:109-116.
2. Gautreau A, Louvard D, Arpin M. ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling. Curr Opin Cell Biol 2002;14:104-109.
3. Mangeat P, Roy C, Martin M. ERM proteins in cell adhesion and membrane dynamics. Trends Cell Biol 1999;9:187-192.
4. McClatchey AI. Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer 2003;3:877-883.
5. Bretscher A, Edwards K, Fehon RG. ERM Proteins and Merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 2002;3:586-599.
6. Pokutta S, Weis WI. The cytoplasmic face of cell contact sites. Curr Opin Struct Biol 2002;12:255-262.
7. Berryman M, Franck Z, Bretscher A. Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 1993;105:1025-1043.
8. Schwartz-Albiez R, Merling A, Spring H, et al. Differential expression of the microspike-associated protein moesin in human tissues. Eur J Cell Biol 1995;67:189-198.
9. Hunter KW. Ezrin, a key component in tumor metastasis. Trends Mol Med 2004;10:201-204.
10. Ichikawa T, Masumoto J, Kaneko M, et al. Expression of moesin and associated molecule CD44 in epithelial skin tumors. J Cutan Pathol 1998;25:237-243.
11. Kobayashi H, Sagara J, Masuumoto J, et al. Shifts in cellular localization of moesin in normal oral epithelium, oral epithelial dysplasia, verrucous carcinoma and oral squamous cell carcinoma. J Oral Pathol Med 2003;32:344-349.
12. Kobayashi H, Sagara J, Kurita H, et al. Clinical significance of cellular distribution of moesin in patients with oral squamous cell carcinoma. Clin Cancer Res 2004;10:572-580.
13. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
14. Hanna E, Shrieve DC, Ratanatharathorn V, et al. A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck. Cancer Res 2001;61:2376-2380.
15. Alevizos I, Mahadevappa M, Zhang X, et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 2001;20:6196-6204.
16. Al Moustafa AE, Aoui-Jamali MA, Batist G, et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002;21:2634-2640.
17. Villaret DB, Wang T, Dillon D, et al. Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 2000;110:374-381.
18. Belbin TJ, Singh B, Smith RV, et al. Molecular profiling of tumor progression in head and neck cancer. Arch Otolaryngol Head Neck Surg 2005;131:10-18.
19. Ginos MA, Page GP, Michalowicz BS, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 2004;64:55-63.
20. Gonzalez HE, Gujrati M, Frederick M, et al. Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2003;129:754-759.
21. Mendez E, Cheng C, Farwell DG, et al. Transcriptional expression profiles of oral squamous cell carcinomas. Cancer 2002;95:1482-1494.
22. El-Naggar AK, Kim HW, Clayman GL, et al. Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classification. Oncogene 2002;21:8206-8219.
23. Chung CH, Parker JS, Karaca G, et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004;5:489-500.
24. Belbin TJ, Singh B, Barber I, et al. Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 2002;62:1184-1190.
25. Ha PK, Benoit NE, Yochem R, et al. A transcriptional progression model for head and neck cancer. Clin Cancer Res 2003;9:3058-3064.
26. Gunn-Moore FJ, Welsh GI, Herron LR, et al. A novel 4.1 ezrin, radixin, moesin (FERM) containing protein, "Willin." FEBS Lett 2005;579:5089-5094.
27. Chung GG, Provost E, Kielhorn EP, et al. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis. Clin Cancer Res 2001;7:4013-4020.
28. Hoos A, Urist MJ, Stojadinovic A, et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 2001;158:1245-1251.
29. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993;138:923-936.
30. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
31. Martin TA, Harrison G, Mansel RE, Jiang WG. The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol 2003;46:165-186.
32. Wang W, Goswami S, Lapidus K, et al. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 2004;64:8585-8594.
33. Tokunou M, Niki T, Saitoh Y, et al. Altered expression of the ERM proteins in lung adenocarcinoma. Lab Invest 2000;80:1643-1650.
34. Sanchez-Carbayo M, Socci ND, Charytonowicz E, et al. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res 2002;62:6973-6980.
35. Ohtani K, Sakamoto H, Rutherford T, et al. Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Cancer Lett 2002;179:79-86.
36. Lallemand D, Curto M, Saotome I, et al. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev 2003;17:1090-1100.
37. Batchelor CL, Woodward AM, Crouch DH. Nuclear ERM (ezrin, radixin, moesin) proteins: regulation by cell density and nuclear import. Exp Cell Res 2004;296:208-222.
38. Muranen T, Gronholm M, Renkema GH, Carpen O. Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin. Oncogene 2005;24:1150-1158.
39. Morrison H, Sherman LS, Legg J, et al. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 2001;15:968-980.